GGrantIndex
← Leaderboards

Adam S Helms

University Of Michigan At Ann Arbor

$3,584,289
Attributed
$3,584,289
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,584,289 · 5

By mechanism

R01$2,132,393 · 2
K08$817,598 · 1
R56$478,298 · 1
R03$156,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Cardiac

Research focus

CardiacGeneticInduced Pluripotent Stem CellGenesCardiac MyocytesCellsPhenotypeMyocardiumProteinsLoss Of FunctionHeart FailureArrhythmiaHeartLeadMouse ModelCalciumFunctional DisorderAffectFutureIn VivoHypertrophic CardiomyopathyPathway InteractionsCrispr/Cas TechnologyMutation

Grant awards (11)

Cis regulatory variants of haploinsufficiency genes as cardiomyopathy modifiers$725,005
R01 · FY2025 · HL · contact PI
Stoichiometric, adhesion, and contractile deficits in desmoplakin cardiomyopathy$651,349
R01 · FY2025 · HL · contact PI
Cis regulatory variants of haploinsufficiency genes as cardiomyopathy modifiers$756,039
R01 · FY2024 · HL · contact PI
Development of a high throughput microtissue model for integrative analysis of contractile function and biomechanical stress in iPSC-derived cardiomyocytes$78,000
R03 · FY2022 · HL · contact PI
Dissection and Rescue of Mechanical and Transcriptional Defects in Desmoplakin Cardiomyopathy$478,298
R56 · FY2021 · HL · contact PI
Development of a high throughput microtissue model for integrative analysis of contractile function and biomechanical stress in iPSC-derived cardiomyocytes$78,000
R03 · FY2021 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2020 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2019 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,620
K08 · FY2018 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,325
K08 · FY2017 · HL · contact PI
Genome-Engineered Stem Cell Models to Determine Disease Mechanisms in MYBPC3 Hypertrophic Cardiomyopathy$163,413
K08 · FY2016 · HL · contact PI